Stat

Talkspace hits an earnings milestone, Hims acquisition,...

This is the web edition of STAT’s Health Tech newsletter, our guide to how techn...

Risky weight loss, grad school acceptance cuts, and mor...

The latest from the biopharma world, brought to you by The Readout.

STAT+: Pharmalittle: We’re reading about Trump and phar...

In today's Pharmalittle roundup, Trump and pharma tariffs, losing too much weigh...

The U.S. could face a national hospital bed shortage

Grad school applicants in limbo, muscle dysmorphia, and other health news storie...

STAT+: Why biotech’s future is threatened by zombies

The state of the biotech investing is dark. Here's one reason why.

Opinion: The health policy cult’s misplaced faith in go...

If the past teaches us anything, it is that no one should expect the government ...

STAT+: Years after an Apple study, its tech has birthed...

Based on an Apple study, researchers have developed a free asthma management too...

Opinion: HHS’ national health security division must be...

The small but mighty Administration for Strategic Preparedness and Response at H...

STAT+: How much weight loss is too much? Pharma is push...

How much weight loss is too much? Pharma is pushing the limit with new obesity d...

STAT+: Medical device lobby pushes back against Trump’s...

AdvaMed, the medical device lobby, pushed back Wednesday on the Trump administra...

Graduate student admissions paused and cut back as univ...

In response to Trump science policies, universities are accepting fewer graduate...

STAT+: Trump is giving Republicans a seemingly impossib...

It’s only possible to lower taxes without touching major government entitlement ...

STAT+: Dr. Oz plans to sell insurance, hospital, and ph...

Dr. Oz's assets range from a tree trimming company to a cattle farm to UnitedHea...

STAT+: Health AI: How recent FDA layoffs could shift re...

Tech adoption might slow down if the FDA layoffs shift responsibility for medica...

STAT+: Pharmalittle: We’re reading about Trump tariffs ...

President Trump told reporters that tariffs on pharmaceuticals would start at "2...

Tumult in FDA’s medical device center; one CEO speaks o...

The essential biotech news stories of the day, brought to you by The Readout.

One issue that RFK Jr. and his critics agree on 

Plus more valuable health news stories of the day.

Opinion: The Kansas City TB outbreak shows the value of...

The tuberculosis outbreak in the Kansas City area is not, in fact, the largest i...

STAT+: The ‘GRAS’ loophole lets untested additives into...

RFK Jr. wants to tackle the GRAS exemption, which allows companies to put chemic...

Opinion: STAT+: Recursion CEO: Publicly funded research...

If policymakers fail to act swiftly to restore medical research funding, then it...

Trump signs order to expand IVF by making it more affor...

According to a fact sheet provided by the White House, Trump's IVF order will fo...

STAT+: Generic drugmakers win a long-running battle wit...

A judge in California has ruled that a law banning so-called pay-to-delay deals ...

Opinion: The ‘disease detectives’ dodged a bullet — but...

“While the EIS program has likely been spared this time, the fact that its exist...

STAT+: FDA’s former top food official says Trump firing...

The former head of the FDA's food division told STAT he resigned because cuts ma...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.